Greenway Medical goes public

Luke Gale | | Health Exec | Policy & Regulations
Health IT vendor Greenway Medical went public Feb. 2, offering an initial public offering will make available approximately 6.7 million shares of common stock at $10 per share.

The shares began trading on the New York Stock Exchange Feb. 2 under the symbol “GWAY.”

J.P. Morgan and Morgan Stanley are acting as active book-runners for the Carrollton, Ga.-based company.

Luke Gale

Related Content

Report: 44% of adults in the U.S. are uninsured or underinsured
Texas AG sues hospital for $10K after off-duty police barred from carrying guns
Cardiologists reflect on developing primary PCI in face of criticism and pushback
PBMs sue FTC for alleged Fifth Amendment violation
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”